Business Description
![Advaxis Inc Advaxis Inc logo](https://static.gurufocus.com/logos/0C00000YGK.png?14)
Advaxis Inc
NAICS : 325414
SIC : 2834
ISIN : US0076242082
Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -27.97 | |||||
12-1 Month Momentum % | -76.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -7098.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 0.44 | |||||
EV-to-EBITDA | 0.45 | |||||
EV-to-Revenue | -41.65 | |||||
Earnings Yield (Greenblatt) % | 227.27 | |||||
FCF Yield % | -2329.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advaxis Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.254 | ||
EPS (TTM) ($) | -9.93 | ||
Beta | 0 | ||
Volatility % | 122.17 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.114643 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | -76.32 | ||
52-Week Range ($) | 0.1 - 4.5 | ||
Shares Outstanding (Mil) | 4.84 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Advaxis Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Advaxis Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Advaxis Inc Frequently Asked Questions
What is Advaxis Inc(ADXS)'s stock price today?
The current price of ADXS is $0.16. The 52 week high of ADXS is $4.50 and 52 week low is $0.10.
When is next earnings date of Advaxis Inc(ADXS)?
The next earnings date of Advaxis Inc(ADXS) is .
Does Advaxis Inc(ADXS) pay dividends? If so, how much?
Advaxis Inc(ADXS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |